GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
Monday Opens to S&P 500 Climb, Dow Slides as Eyes Look Toward Nvidia | Live Stock
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
'Novo Nordisk Launches Wegovy in China With Prices Well Below US' - Bloomberg News
MonkeyGee : maybe gap down
Stock_Drift : Maybe…gap, gap, all around.